LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(18.18%)
USD 0.0
(18.18%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 787.21 Million USD | 3.22% |
| 2022 | 762.66 Million USD | -41.22% |
| 2021 | 1.29 Billion USD | -4.75% |
| 2020 | 1.36 Billion USD | -8.87% |
| 2019 | 1.49 Billion USD | 13.87% |
| 2018 | 1.31 Billion USD | 81.66% |
| 2017 | 722.65 Million USD | 20.12% |
| 2016 | 601.58 Million USD | 19.58% |
| 2015 | 503.06 Million USD | 94.96% |
| 2014 | 258.02 Million USD | 146.42% |
| 2013 | 104.71 Million USD | 0.43% |
| 2012 | 104.26 Million USD | -14.79% |
| 2011 | 122.35 Million USD | 61.93% |
| 2010 | 75.55 Million USD | -46.72% |
| 2009 | 141.8 Million USD | -17.29% |
| 2008 | 171.44 Million USD | -1.06% |
| 2007 | 173.27 Million USD | -46.86% |
| 2006 | 326.05 Million USD | 109.75% |
| 2005 | 155.45 Million USD | -20.88% |
| 2004 | 196.47 Million USD | -26.2% |
| 2003 | 266.23 Million USD | 1719.03% |
| 2002 | -16.44 Million USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 866.4 Million USD | -5.19% |
| 2024 Q1 | 913.86 Million USD | 16.09% |
| 2023 Q2 | 758.1 Million USD | -6.53% |
| 2023 Q1 | 811.07 Million USD | 6.35% |
| 2023 Q3 | 769.22 Million USD | 1.47% |
| 2023 Q4 | 787.21 Million USD | 2.34% |
| 2023 FY | 787.21 Million USD | 3.22% |
| 2022 Q1 | 1.1 Billion USD | -14.83% |
| 2022 FY | 762.66 Million USD | -41.22% |
| 2022 Q2 | 1.07 Billion USD | -2.61% |
| 2022 Q4 | 762.66 Million USD | -27.41% |
| 2022 Q3 | 1.05 Billion USD | -2.39% |
| 2021 Q2 | 1.25 Billion USD | -3.0% |
| 2021 Q1 | 1.29 Billion USD | -4.93% |
| 2021 FY | 1.29 Billion USD | -4.75% |
| 2021 Q4 | 1.29 Billion USD | 1.88% |
| 2021 Q3 | 1.27 Billion USD | 1.38% |
| 2020 Q4 | 1.36 Billion USD | 9.21% |
| 2020 Q1 | 1.18 Billion USD | -20.67% |
| 2020 Q2 | 1.24 Billion USD | 4.81% |
| 2020 Q3 | 1.24 Billion USD | 0.36% |
| 2020 FY | 1.36 Billion USD | -8.87% |
| 2019 Q1 | 1.91 Billion USD | 51.81% |
| 2019 Q4 | 1.49 Billion USD | -3.4% |
| 2019 Q3 | 1.54 Billion USD | -14.12% |
| 2019 FY | 1.49 Billion USD | 13.87% |
| 2019 Q2 | 1.8 Billion USD | -5.86% |
| 2018 Q4 | 1.26 Billion USD | -40.13% |
| 2018 Q2 | 1.85 Billion USD | 146.24% |
| 2018 Q1 | 754.66 Million USD | 12.47% |
| 2018 Q3 | 2.1 Billion USD | 13.32% |
| 2018 FY | 1.31 Billion USD | 81.66% |
| 2017 Q2 | 640.02 Million USD | 1.64% |
| 2017 FY | 722.65 Million USD | 20.12% |
| 2017 Q4 | 671.02 Million USD | 1.31% |
| 2017 Q3 | 662.33 Million USD | 3.49% |
| 2017 Q1 | 629.72 Million USD | 4.68% |
| 2016 Q3 | 600.86 Million USD | 1.96% |
| 2016 FY | 601.58 Million USD | 19.58% |
| 2016 Q4 | 601.58 Million USD | 0.12% |
| 2016 Q2 | 589.31 Million USD | 0.57% |
| 2016 Q1 | 585.95 Million USD | 9.74% |
| 2015 Q2 | 304.76 Million USD | 15.78% |
| 2015 Q1 | 263.22 Million USD | 2.01% |
| 2015 FY | 503.06 Million USD | 94.96% |
| 2015 Q4 | 533.92 Million USD | 2.34% |
| 2015 Q3 | 521.7 Million USD | 71.18% |
| 2014 Q3 | 272.28 Million USD | 172.7% |
| 2014 Q2 | 99.84 Million USD | -5.33% |
| 2014 Q1 | 105.47 Million USD | 0.72% |
| 2014 FY | 258.02 Million USD | 146.42% |
| 2014 Q4 | 258.02 Million USD | -5.23% |
| 2013 FY | 104.71 Million USD | 0.43% |
| 2013 Q2 | 99.57 Million USD | 1.23% |
| 2013 Q3 | 101.67 Million USD | 2.12% |
| 2013 Q1 | 98.36 Million USD | -5.66% |
| 2013 Q4 | 104.71 Million USD | 2.99% |
| 2012 Q1 | 110.03 Million USD | -10.07% |
| 2012 FY | 104.26 Million USD | -14.79% |
| 2012 Q2 | 102.82 Million USD | -6.55% |
| 2012 Q3 | 97.5 Million USD | -5.17% |
| 2012 Q4 | 104.26 Million USD | 6.93% |
| 2011 Q3 | 123.15 Million USD | -3.77% |
| 2011 Q1 | 134.69 Million USD | 78.26% |
| 2011 Q2 | 127.97 Million USD | -4.99% |
| 2011 Q4 | 122.35 Million USD | -0.66% |
| 2011 FY | 122.35 Million USD | 61.93% |
| 2010 Q1 | 133.62 Million USD | -5.77% |
| 2010 Q2 | 127.59 Million USD | -4.51% |
| 2010 Q3 | 112.56 Million USD | -11.78% |
| 2010 FY | 75.55 Million USD | -46.72% |
| 2010 Q4 | 75.55 Million USD | -32.88% |
| 2009 FY | 141.8 Million USD | -17.29% |
| 2009 Q4 | 141.8 Million USD | 21.11% |
| 2009 Q3 | 117.08 Million USD | -9.36% |
| 2009 Q2 | 129.17 Million USD | -7.46% |
| 2009 Q1 | 139.58 Million USD | -18.58% |
| 2008 Q4 | 171.44 Million USD | 16.48% |
| 2008 Q3 | 147.19 Million USD | -8.02% |
| 2008 Q2 | 160.02 Million USD | -3.75% |
| 2008 Q1 | 166.26 Million USD | -4.05% |
| 2008 FY | 171.44 Million USD | -1.06% |
| 2007 Q2 | 228.47 Million USD | -56.47% |
| 2007 Q3 | 211.52 Million USD | -7.42% |
| 2007 Q4 | 173.27 Million USD | -18.08% |
| 2007 Q1 | 524.81 Million USD | 60.96% |
| 2007 FY | 173.27 Million USD | -46.86% |
| 2006 Q2 | 285.93 Million USD | -0.96% |
| 2006 Q4 | 326.05 Million USD | 40.62% |
| 2006 FY | 326.05 Million USD | 109.75% |
| 2006 Q3 | 231.86 Million USD | -18.91% |
| 2006 Q1 | 288.68 Million USD | 85.71% |
| 2005 Q3 | 306.04 Million USD | 1.43% |
| 2005 Q4 | 155.45 Million USD | -49.21% |
| 2005 FY | 155.45 Million USD | -20.88% |
| 2005 Q1 | 313.25 Million USD | 59.44% |
| 2005 Q2 | 301.72 Million USD | -3.68% |
| 2004 Q2 | 285.31 Million USD | -3.02% |
| 2004 Q1 | 294.18 Million USD | 91.46% |
| 2004 Q4 | 196.47 Million USD | 0.0% |
| 2004 FY | 196.47 Million USD | -26.2% |
| 2003 Q4 | 153.65 Million USD | -43.67% |
| 2003 Q1 | 72.24 Million USD | 309.4% |
| 2003 Q2 | 65.81 Million USD | -8.89% |
| 2003 FY | 266.23 Million USD | 1719.03% |
| 2003 Q3 | 272.79 Million USD | 314.48% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | -16.44 Million USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q3 | 58.41 Million USD | 0.0% |
| 2002 Q4 | -34.49 Million USD | -159.05% |
| 2001 FY | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | -Infinity% |
| Allstar Health Brands, Inc. | 220.00 USD | -357825354.545% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 567.74 Million USD | -38.657% |
| Café Serendipity Holdings, Inc. | 1.04 Million USD | -75225.62% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | 501.27 Thousand USD | -156941.488% |
| HealthWarehouse.com, Inc. | 3.2 Million USD | -24435.282% |
| MedGen, Inc. | 0.79 USD | -99647594836.709% |
| Omni Health, Inc. | 5.53 Million USD | -14131.32% |
| Oxford Investments Holdings Inc. | 451.08 Thousand USD | -174417.659% |
| Pineapple, Inc. | 7.83 Million USD | -9941.489% |
| ScripsAmerica, Inc. | 5.64 Million USD | -13847.749% |